Skip to main content
. 2019 Dec 19;146(2):160–167. doi: 10.1001/jamaoto.2019.3969

Table 1. Clinical Characteristics of Patients With vs Without UVFIa.

Characteristic UVFI (n = 7) No UVFI (n = 93) OR (95% CI)
Demographics
Age, median (range), y 62.0 (39.0-77.0) 58.0 (19.0-87.0) 1.0 (0.9-1.1)
Male sex 4 (57) 58 (62) 0.8 (0.2-3.8)
White race 5 (71) 76 (82) 0.9 (0.1-7.9)
BMI, median (range) 34.7 (22.1-60.3) 29.6 (14.4-77.0) 1.0 (0.9-1.1)
Comorbidities
Myocardial infarction 2 (29) 16 (17) 1.9 (0.3-10.8)
Percutaneous coronary intervention, stent, or angina 3 (43) 12 (13) 5.1 (1.0-25.5)
Chronic pulmonary disease 3 (43) 32 (34) 1.4 (0.3-6.8)
Congestive heart failure 3 (43) 25 (27) 2.0 (0.4-9.8)
Hypertension requiring medical therapy 3 (43) 47 (51) 0.7 (0.2-3.5)
Peripheral vascular disease 3 (43) 10 (11) 6.2 (1.2-31.9)
Transient ischemic attack or cerebrovascular accident 1 (14) 7 (8) 2.0 (0.2-19.5)
Diabetes 2 (29) 34 (37) 0.7 (0.1-3.8)
Charlson Comorbidity Index, median (range) 6 (3-8) 5 (0-13) 1.0 (0.8-1.3)
Modified Frailty Index Score, median (range) 0.18 (0-0.64) 0.18 (0-0.91) 5.5 (0.2-161.0)
Active problems during intubation
Hypotension 7 (100) 43 (46) 11 (1.6-∞)
Vasopressor requirement 7 (100) 33 (35) 17 (2.4-∞)
Acute kidney injury 5 (71) 44 (47) 2.8 (0.5-15)
Systemic corticosteroids 4 (57) 28 (30) 3.1 (0.6-15)
Delirium 5 (71) 63 (68) 1.2 (0.2-6.5)
Pneumonia 2 (29) 35 (38) 0.7 (0.1-3.6)
Acute respiratory distress syndrome 1 (14) 10 (11) 1.4 (0.2-12.7)
Nasogastric or orogastric tube 4 (57) 58 (62) 0.8 (0.2-3.8)

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); OR, odds ratio; UVFI, unilateral vocal fold immobility.

a

Data are presented as number (percentage) of patients unless otherwise indicated.